Infectious Diseases
June 14, 2022
ROCHESTER, Minn. — Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir and ritonavir,[...]
January 12, 2017
January 9, 2017
January 5, 2017
January 2, 2017
January 1, 2017
December 30, 2016
December 29, 2016
December 28, 2016
December 26, 2016
December 22, 2016
December 19, 2016
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community